BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.51
0.00 (0.00%)
At close: May 15, 2026, 4:00 PM EDT
8.40
-0.11 (-1.29%)
After-hours: May 15, 2026, 7:41 PM EDT

BBOT Stock Forecast

Stock Price Forecast

The 8 analysts that cover BBOT stock have a consensus rating of "Strong Buy" and an average price target of $23.88, which forecasts a 180.61% increase in the stock price over the next year. The lowest target is $20 and the highest is $29.

Price Target: $23.88 (+180.61%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$20$23.88$24$29
Change+135.02%+180.61%+182.02%+240.78%

Analyst Ratings

The average analyst rating for BBOT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy112223
Buy455555
Hold000000
Sell000000
Strong Sell000000
Total567778

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Strong Buy
Initiates
$23
Strong BuyInitiates$23+170.27%May 11, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$27$29
Strong BuyMaintains$27$29+240.78%Mar 6, 2026
Stifel
Stifel
Strong Buy
Initiates
$23
Strong BuyInitiates$23+170.27%Feb 11, 2026
Raymond James
Raymond James
Buy
Initiates
$24
BuyInitiates$24+182.02%Jan 9, 2026
Wedbush
Wedbush
Buy
Reiterates
$25
BuyReiterates$25+193.77%Dec 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.26
from -4.30
EPS Next Year
-2.22
from -2.26
Fiscal YearFY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
-------
Revenue Growth
-------
EPS
-518.73-5,756.41-4.30-2.26-2.22-2.19-2.00
EPS Growth
-------
Forward PE
-------
No. Analysts
---1110106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030203120322033
High-1.96-1.87
Avg-2.26-2.22
Low-2.56-2.53

EPS Growth

EPS Growth20262027202820292030203120322033
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.